Page last updated: 2024-09-03

hrp 102 and trisequens

hrp 102 has been researched along with trisequens in 2 studies

Compound Research Comparison

Studies
(hrp 102)
Trials
(hrp 102)
Recent Studies (post-2010)
(hrp 102)
Studies
(trisequens)
Trials
(trisequens)
Recent Studies (post-2010) (trisequens)
3319856351

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cacciatore, B; Hasselblatt, R; Nieminen, MS; Paakkari, I; Tikkanen, MI; Toivonen, J; Ylikorkala, O1
Strandberg, TE; Tikkanen, MJ; Ylikorkala, O1

Trials

2 trial(s) available for hrp 102 and trisequens

ArticleYear
Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    American journal of obstetrics and gynecology, 2001, Volume: 184, Issue:5

    Topics: Administration, Cutaneous; Administration, Oral; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Prospective Studies; Statistics, Nonparametric

2001
Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
    The American journal of cardiology, 2003, Jul-15, Volume: 92, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Middle Aged; Norethindrone; Reference Values; Risk Factors

2003